David S Shulman, MD
David S Shulman, MD
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas | Ewing sarcoma, Myosarcoma, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, connective tissue neoplasm, desmoplastic small round cell tumor, myomatous neoplasm, neoplasm, osteosarcoma, rhabdomyosarcoma, sarcoma | Recruiting | Phase 1 / Phase 2 | 2026-02-19 | NCT06709495 |